Roepcke, Stefan Max Planck Society;
Kristiansen, G., Pilarsky, C., Wissmann, C., Kaiser, S., Bruemmendorf, T., Roepcke, S., et al. (2005). Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. The Journal of Pathology, 205(3), 359-376. doi:10.1002/path.1676.